±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 158  |  »Ø¸´: 0
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£

haixianggao

½ð³æ (СÓÐÃûÆø)

[½»Á÷] PfizerÍ£Ö¹ÁËÐÂÒ»´ú½µÑªÖ¬Ò©µÄÁÙ´²ÊÔÑé

±ê  Ìâ: PfizerÍ£Ö¹ÁËÐÂÒ»´ú½µÑªÖ¬Ò©µÄÁÙ´²ÊÔÑé
·¢ÐÅÕ¾: BBS δÃû¿Õ¼äÕ¾ (Sun Dec  3 01:15:54 2006), תÐÅ

NEW YORK - Pfizer Inc. said Saturday it has cut off all clinical trials and
development for a cholesterol drug that was supposed to be the star of its p
ipeline because of an unexpected number of deaths and cardiovascular problem
s in patients who used it.

ÔÚ»¨Á˳¬¹ý13ÒÚÃÀÔªÖ®ºó, Pfzier»¹ÊǰÑÕâ¸öÒ©¸øÍ£µôÁË. Õâ¸öÒ©¾ÍÊÇÎÒÉϴνéÉܸ÷¸ö
´óÒ©³§µÄÏÖʵ״¿öʱÌáµ½¹ýµÄ, Pfizer¼Æ»®ÓÃÀ´È¡´úLipitorµÄÏÂÒ»´ú½µÑªÖ¬µÄÒ©Æ·. Ïà
±ÈÓÚ½«Òª×¨Àû¹ýÆÚµÄlipitorÀ´Ëµ, Õâ¸öÒ©¿ÉÒÔÉý¸ßHDL. ±¾À´PfizerÉèÏëÒªÔÚÕâ¸öÒ©±»
Åú×¼ºóºÍÏÖÔÚ½µLDLµÄLipitorÁªºÍÓÃÒ©. ÕâÑù¼´Ê¹lipitorµÄרÀûÔÚ2010Äê¹ýÆÚÖ®ºóÒ²ÄÜ
ͨ¹ýÕâÖÖ·½·¨°ÑËùÓеÄlipitorÊг¡×ªµ½Õâ¸öÐÂÒ©À´, ¾ÍÏóÏÖÔÚµÄVytorinÊÇÓÃÀ´×ª»¯Zo
corµÄÊг¡Ò»Ñù. µ«ÃÎÏëÊÇÃÀºÃµÄ, ÏÖʵȷʵ²Ð¿áµÄ. 13ÒÚÃÀÔª¾ÍÕâÑù´òˮƮ¶ùÁË. ²»¹ý
ÕâÒ²²»ÊÇpfizerµÚÒ»´ÎÕâÑùÔÒÇ®ÁË, ÏàÐÅÒ²²»»áÊÇ×îºóÒ»´Î.

Torcetrapib, just two days ago, Pfizer had said it hoped to file an applicat
ion with the FDA for approval of torcetrapib by the second half of next year
. But on Saturday, the company said the loss of the drug will not affect its
financial guidance for 2006. ¿´¿´ÖÜһʱpfizerµÄ¹ÉƱ»áµø¶àÉÙ, ÎÒ¹À¼Æ5%ÊÇÖÁÉÙ
µÄ.

ÏÖÔÚPfizerÄÜ×öµÄ×îºÃÑ¡Ôñ¾ÍÊÇÊÕ¹ºÊÕ¹ºÔÙÊÕ¹º, ÕùÈ¡ÂòÏÂһЩ±È½ÏÓÐÏ£ÍûµÄ¹«Ë¾, È»
ºóͨ¹ý×Ô¼ºÇ¿´óµÄsales¶ÓÎé°ÑËûÃǵIJúÆ·Ò»¸ö¸öµÄÍÆ³Éblockbuster. µ«ÊÇËûÃÇÊÖ±ßÖ»
ÓÐ13 billionµÄÏÖ½ðreserve, ÊÕ¹ºÊ±µÄtargetÑ¡ÔñÒ²¹»ËûÃÇ·ÑÄÔ×ÓµÄ. ÏÖÔÚÕâÖÖÇé¿ö²¢
²»ÊǼòµ¥µÄcut 20% sales force¾ÍÄܽâ¾öµÄÁË.

Patent expirations will cost the company $14 billion in annual sales between
2005 and 2007, the company said. Lipitor, which had $12.2 billion in sales
last year, may lose patent protection by 2010.
»Ø¸´´ËÂ¥
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ haixianggao µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 083000»·¾³¿ÆÑ§Ó빤³Ìµ÷¼Á£¬×Ü·Ö281 +4 ³È×Ó£¨Ê¤Ò⣩ 2026-03-30 4/200 2026-03-31 00:44 by Linzejun
[¿¼ÑÐ] µ÷¼Á +4 GK72 2026-03-30 4/200 2026-03-30 20:32 by dick_runner
[¿¼ÑÐ] 279Çóµ÷¼Á +12 jµÄÁ¢·½ 2026-03-29 12/600 2026-03-30 20:30 by dick_runner
[¿¼ÑÐ] 367Çóµ÷¼Á +5 ÓóÄàà£à£¡­ 2026-03-28 5/250 2026-03-30 19:56 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 359Çóµ÷¼Á +5 ÍõÁ˸öéª 2026-03-25 5/250 2026-03-30 19:36 by Ô´_2020
[¿¼ÑÐ] 070300»¯Ñ§354Çóµ÷¼Á +7 101´ÎÏ£Íû 2026-03-28 7/350 2026-03-30 13:22 by Iveryant
[¿¼ÑÐ] 0703±¾¿ÆÖ£ÖÝ´óѧÇóµ÷¼Á +7 nhj_ 2026-03-25 7/350 2026-03-30 12:44 by fangnagu
[¿¼ÑÐ] »¯Ñ§¹¤³Ì085602 305·ÖÇóµ÷¼Á +25 RichLi_ 2026-03-25 25/1250 2026-03-30 11:02 by klasasda
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©¹¤Òµ´óѧ£¬324·ÖÇóµ÷¼Á +6 Áã°Ë# 2026-03-28 6/300 2026-03-29 21:20 by nanaliuyun
[¿¼ÑÐ] Ò»Ö¾Ô¸±±¾©Àí¹¤´óѧ±¾¿Æ211²ÄÁϹ¤³Ì294Çóµ÷¼Á +8 mikasaµÄΧ½í 2026-03-28 8/400 2026-03-29 12:48 by Î޼ʵIJÝÔ­
[¿¼ÑÐ] 332Çó92µ÷¼Á +8 ½¶½¶123 2026-03-28 8/400 2026-03-29 10:46 by ÖÜè÷µ¤
[¿¼ÑÐ] 311£¨085601£©Çóµ÷¼Á +4 liziyeyeye 2026-03-28 4/200 2026-03-28 18:50 by 535743368
[¿¼ÑÐ] ±¾¿ÆÐÂÄÜÔ´¿ÆÑ§Ó빤³Ì£¬Ò»Ö¾Ô¸»ªÀíÄܶ¯285Çóµ÷¼Á +3 AZMK 2026-03-27 5/250 2026-03-28 16:19 by xxxsssccc
[¿¼ÑÐ] 299Çóµ÷¼Á +7 àÅàÅàÅàÅ2 2026-03-27 7/350 2026-03-28 13:09 by ÌÆãå¶ù
[¿¼ÑÐ] 266Çóµ÷¼Á +11 ÑôÑôÍÛÈû 2026-03-27 12/600 2026-03-27 17:56 by yu221
[¿¼ÑÐ] 292Çóµ÷¼Á +4 ÇóÇóÁËÊÕÏÂÎÒ°É£ 2026-03-26 4/200 2026-03-27 10:37 by zhshch
[˶²©¼ÒÔ°] ±±¾©ÁÖÒµ´óѧ˶µ¼ÕÐÉú¹ã¸æ +6 kongweilin 2026-03-26 8/400 2026-03-27 10:18 by FF_16
[¿¼ÑÐ] Çóµ÷¼Á +6 ÁÖ֮Ϧ 2026-03-24 6/300 2026-03-27 08:38 by hypershenger
[¿¼ÑÐ] ÍøÂç¿Õ¼ä°²È«0839Õе÷¼Á +4 w320357296 2026-03-25 6/300 2026-03-25 17:59 by 255671
[¿¼ÑÐ] µ÷¼Á +4 13853210211 2026-03-24 4/200 2026-03-24 19:44 by ms629
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û